Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-14885

Single-particle
3.7 Å
EMD-14885 Deposition: 03/05/2022
Map released: 01/06/2022
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-14885

OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN

EMD-14885

Single-particle
3.7 Å
EMD-14885 Deposition: 03/05/2022
Map released: 01/06/2022
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4
Sample: OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
Fitted models: 7zr7

Deposition Authors: Duyvesteyn HME, Ren J , Stuart DI
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.
PUBMED: 35662412
DOI: doi:10.1016/j.cell.2022.05.014
ISSN: 1097-4172